Demographic | | | |
Age years (median (IQR)) | 62.0 (23.0) | 61.0 (24.0) | 0.37 |
Men | 63 (64) | 23 (66) | 0.88 |
Current smoker | 31 (36) | 7 (25) | 0.28 |
Current alcohol consumer | 8 (10) | 2 (7) | >0.99 |
Immunocompromised# | 47 (48) | 25 (71) | 0.017 |
HIV | 8 (8) | 3 (9) | >0.99 |
Transplant | 19 (19) | 9 (26) | 0.43 |
Cancer | 16 (16) | 7 (20) | 0.62 |
Systemic corticosteroids¶ | 21 (21) | 17 (49) | 0.002 |
Diagnosis at ICU admission | | | 0.73 |
Respiratory failure | 59 (60) | 24 (69) | |
Septic shock | 18 (18) | 5 (14) | |
Cardiac failure | 9 (9) | 2 (6) | |
Sepsis | 5 (5) | 1 (3) | |
Other | 7 (7) | 3 (9) | |
Previous antibiotic | 7 (7) | 3 (9) | 0.72 |
Comorbidities+ | 76 (78) | 26 (74) | 0.70 |
Chronic respiratory disease | 27 (28) | 8 (23) | 0.55 |
Chronic cardiovascular disease | 23 (24) | 6 (17) | 0.44 |
Diabetes mellitus | 12 (12) | 6 (17) | 0.57 |
Neurological disease | 11 (11) | 7 (20) | 0.25 |
Chronic renal disease | 12 (12) | 7 (20) | 0.27 |
Chronic liver disease | 4 (4) | 2 (6) | 0.65 |
Arterial hypertension | 38 (39) | 18 (51) | 0.19 |
Laboratory tests (median (IQR)) | | | |
Creatinine mg·mL−1 | 1.0 (1.0) | 1.2 (1.1) | 0.98 |
C-reactive protein mg·dL−1 | 12.5 (15.9) | 11.9 (20.0) | 0.87 |
White blood-cell count 109·L−1 | 10.0 (9.0) | 9.0 (12.0) | 0.41 |
SOFA score at ICU admission (median (IQR)) | 5 (6) | 5 (5) | 0.91 |
Outcomes | | | |
Pulmonary complications | 16 (39) | 5 (33) | 0.70 |
NIMV | 59 (94) | 17 (94) | >0.99 |
IMV | 72 (92) | 26 (93) | >0.99 |
Hospital stay days (median (IQR)) | 35.0 (33.0) | 46.0 (62.0) | 0.017 |
ICU stay days (median (IQR)) | 19.5 (21.5) | 31.5 (69.0) | 0.070 |
30-day mortality | 38 (41) | 21 (64) | 0.024 |